Christopher am Ende – QCB

Christopher am Ende

Thumbnail Image

May 7, 2018

Christopher am Ende

Pfizer, Inc.
Friday, October 28, 2016 at 2:30 p.m. C033
View Flyer

Trainee Spotlight

Morgan Nyman

My research focuses on developing and understanding cancer therapeutics that specifically target diseased tissue inhibiting one-carbon metabolism, and more specifically purine synthesis pathway, within the cell.

Fun Fact: I am a big fan of Jurassic Park.

Degree Program: Biochemistry

Lab: Dann

Undergrad Institution: Gannon University

For those who value speed and simplicity, the pokies net login has been a solid go-to for our team.

More Trainees

Zach Celentano

I am interested in studying the mechanisms of function of quorum sensing inhibitors and developing new inhibitors against Vibrios using a combination of structure based drug design and structure activity relationship assays.

Fun Fact: I have been weightlifting since I was 14 years old (almost 12 years now).

Degree Program: Biochemistry

Lab: van Kessel

Undergrad Institution: Indiana University Bloomington

More Trainees

© 2025 QCB. All Rights Reserved.